Showing results (151-160 of 241) with videos related to
Sort By:
Pageof 25
Journal of Clinical Medicine|October 27, 2022
Is There Indication for the Use of Biological Mesh in Cancer Patients?Renato Patrone, Maddalena Leongito, Raimondo di Giacomo, et al.Environmental Geochemistry and Health|December 13, 2025
Mercury contamination in Brazil related to (historical) artisanal and small-scale gold mining activity: a narrative review with quantitative synthesisMarcelo da Silveira Tortolero Araujo Lourenço, David Debruyne, Rosa Maria Di Maggio, et al.Journal of Experimental & Clinical Cancer Research : CR|March 21, 2024
Cross-reactive CD8<sup>+</sup> T cell responses to tumor-associated antigens (TAAs) and homologous microbiota-derived antigens (MoAs)Beatrice Cavalluzzo, Marie Christine Viuff, Siri Amanda Tvingsholm, et al.Cellular & Molecular Immunology|November 4, 2014
CXCR4 expression affects overall survival of HCC patients whereas CXCR7 expression does notMaria Neve Polimeno, Caterina Ierano, Crescenzo D'Alterio, et al.Journal of Experimental & Clinical Cancer Research : CR|March 19, 2013
Decrease of survivin, p53 and Bcl-2 expression in chemorefractory colorectal liver metastases may be predictive of radiosensivity radiosensivity after radioembolization with yttrium-90 resin microspheresElisa Melucci, Maurizio Cosimelli, Livio Carpanese, et al.Diagnostics (Basel, Switzerland)|January 21, 2023
Immunotherapy Assessment: A New Paradigm for RadiologistsVincenza Granata, Roberta Fusco, Sergio Venanzio Setola, et al.Infectious Agents and Cancer|July 20, 2021
Diagnostic evaluation and ablation treatments assessment in hepatocellular carcinomaVincenza Granata, Roberta Grassi, Roberta Fusco, et al.Oncotarget|January 13, 2016
The dual targeting of insulin and insulin-like growth factor 1 receptor enhances the mTOR inhibitor-mediated antitumor efficacy in hepatocellular carcinomaClaudia Pivonello, Mariarosaria Negri, Maria Cristina De Martino, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 15, 2004
Pegylated arginine deiminase treatment of patients with unresectable hepatocellular carcinoma: results from phase I/II studiesFrancesco Izzo, Paolo Marra, Gerardo Beneduce, et al.Journal of Clinical Medicine|April 23, 2022
Magnetic Resonance Features of Liver Mucinous Colorectal Metastases: What the Radiologist Should KnowVincenza Granata, Roberta Fusco, Federica De Muzio, et al.Pageof 25